UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Pricing of Medicines In Poland – Two-Year Overview Of How The New Law Affected Costs Of Reimbursement

Value in health, 2014-11, Vol.17 (7), p.A413-A414

2014

Volltextzugriff (PDF)

PIH34 - PROGRAM 75+ - FREE MEDICINES FOR THE ELDERLY

Value in health, 2018-10, Vol.21, p.S218-S218

2018

Volltextzugriff (PDF)

Can we determine the optimal cycle length for which half-cycle correction should always be applied?

Value in health, 2013-05, Vol.16 (3), p.A27-A27

2013

Volltextzugriff (PDF)

Cost Effectiveness Evaluation of Canagliflozin in Combination with Metformin and Sulfonylurea in Comparison To Nph Insulin in the Treatment of Type 2 Diabetes Mellitus In Poland

Value in health, 2014-11, Vol.17 (7), p.A351-A351

2014

Volltextzugriff (PDF)

Cost Effectiveness Evaluation of Canagliflozin In Combination With Metformin in the Treatment Of Type 2 Diabetes Mellitus In Poland

Value in health, 2014-11, Vol.17 (7), p.A346-A346

2014

Volltextzugriff (PDF)

PRM82 Verification of Proportional Hazards Assumption in Cost-Effectiveness Analysis (CEA)

Value in health, 2012-11, Vol.15 (7), p.A475-A475

2012

Volltextzugriff (PDF)

PRM80 Proportional Hazards Assumption and Its Impact on Results of Cost-Effectiveness Analysis

Value in health, 2012-11, Vol.15 (7), p.A474-A474

2012

Volltextzugriff (PDF)

PMD40 Burden of SSI in Gastrointestinal, Cardiac and Orthopaedic Surgeries in Korea

Value in health, 2012-11, Vol.15 (7), p.A352-A352

2012

Volltextzugriff (PDF)

PDB13 Bariatric and Metabolic Surgery in China – Efficacy of Minimally Invasive Procedures

Value in health, 2012-11, Vol.15 (7), p.A661-A661

2012

Volltextzugriff (PDF)

PRM1 What is the Evidence on Using Selected Types of Sutures for Abdominal Surgery – Novel Approach to Create Dynamic Tool for Colleting and Reviewing Available Data

Value in health, 2012-11, Vol.15 (7), p.A645-A645

2012

Volltextzugriff (PDF)

PDB3 Epidemiology, Patient Burden and Related Costs of Obesity in China

Value in health, 2012-11, Vol.15 (7), p.A659-A659

2012

Volltextzugriff (PDF)

PIN1 Efficacy and Safety of Tenofovir as Compared With Alternative Treatment Options for Naive Chronic Hepatitis B – a Systematic Review and Mixed Treatment Comparison

Value in health, 2012-11, Vol.15 (7), p.A665-A665

2012

Volltextzugriff (PDF)

Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland

Value in health, 2013-05, Vol.16 (3), p.A165-A165

2013

Volltextzugriff (PDF)

PMH34 Cost-Utility of Amisulpride Compared with First Generation Antipsychotics in Treatment of Schizophrenia in Poland

Value in health, 2011, Vol.14 (7), p.A292-A292

2011

Volltextzugriff (PDF)

PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)

Value in health, 2011, Vol.14 (7), p.A268-A269

2011

Volltextzugriff (PDF)

PDB2 Epidemiology, Patient Burden and Related Costs of Obesity in India

Value in health, 2012-11, Vol.15 (7), p.A659-A659

2012

Volltextzugriff (PDF)

PDB8 Bariatric and Metabolic Surgery in India – Efficacy and Safety of Minimally Invasive Procedures

Value in health, 2012-11, Vol.15 (7), p.A660-A660

2012

Volltextzugriff (PDF)

PCV4 Comparative Efficacy of Maintenance of Sinus Rhythm Versus Rate Control Strategies in the Treatment of Atrial Fibrillation – Systematic Review and Meta-Analyses

Value in health, 2011, Vol.14 (7), p.A364-A364

2011

Volltextzugriff (PDF)

PIN79 Cost-Utility Analysis of Tenofovir in Comparison with Other Nucleoside Analogues (AN) in Chronic Hepatitis B (CHB) Treatment

Value in health, 2011, Vol.14 (7), p.A280-A280

2011

Volltextzugriff (PDF)

PIN2 Safety and Efficacy of Tenofovir as Compared to Other Nucleot(s)ide Analogues in the Treatment of Chronic Hepatitis B – A Systematic review with Mixed Treatment Comparison

Value in health, 2011, Vol.14 (7), p.A265-A265

2011

Volltextzugriff (PDF)

Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

Value in health, 2017-10, Vol.20 (9), p.A589

2017

Volltextzugriff (PDF)

Budget Impact Analysis (BIA) Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

Value in health, 2017-10, Vol.20 (9), p.A578

2017

Volltextzugriff (PDF)

PMD95 - Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

Value in health, 2017-10, Vol.20 (9), p.A589-A589

2017

Volltextzugriff (PDF)

PMD32 - Budget Impact Analysis (BIA) Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

Value in health, 2017-10, Vol.20 (9), p.A578-A578

2017

Volltextzugriff (PDF)

PRS40 Cost-Utility of Fluticasone Compared with Beclomethasone and Budesonid in Chronic Obstructive Pulmonary Disease (COPD) in Poland

Value in health, 2011, Vol.14 (7), p.A494-A494

2011

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(87)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Internal Medicine
(57)
Science & Technology
(7)
Life Sciences & Biomedicine
(4)
Humans
(3)
Technology
(3)
Analysis
(2)
Artificial Limbs
(2)
Biodiversity
(2)
Cost Analysis
(2)
Implants
(2)
Intravenous Administration
(2)
Ischemia
(2)
Materials Science
(2)
Materials Science, Multidisciplinary
(2)
Medicin Och Hälsovetenskap
(2)
Patients
(2)
Physical Sciences
(2)
Sensitivity Analysis
(2)
Stroke
(2)
T-Plasminogen Activator
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pricing of Medicines In Poland – Two-Year Overview Of How The New Law Affected Costs Of Reimbursement

PIH34 - PROGRAM 75+ - FREE MEDICINES FOR THE ELDERLY

Can we determine the optimal cycle length for which half-cycle correction should always be applied?

Cost Effectiveness Evaluation of Canagliflozin in Combination with Metformin and Sulfonylurea in Comparison To Nph Insulin in the Treatment of Type 2 Diabetes Mellitus In Poland

Cost Effectiveness Evaluation of Canagliflozin In Combination With Metformin in the Treatment Of Type 2 Diabetes Mellitus In Poland

PRM82 Verification of Proportional Hazards Assumption in Cost-Effectiveness Analysis (CEA)

PRM80 Proportional Hazards Assumption and Its Impact on Results of Cost-Effectiveness Analysis

PMD40 Burden of SSI in Gastrointestinal, Cardiac and Orthopaedic Surgeries in Korea

PDB13 Bariatric and Metabolic Surgery in China – Efficacy of Minimally Invasive Procedures

PRM1 What is the Evidence on Using Selected Types of Sutures for Abdominal Surgery – Novel Approach to Create Dynamic Tool for Colleting and Reviewing Available Data

PDB3 Epidemiology, Patient Burden and Related Costs of Obesity in China

PIN1 Efficacy and Safety of Tenofovir as Compared With Alternative Treatment Options for Naive Chronic Hepatitis B – a Systematic Review and Mixed Treatment Comparison

Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland

PMH34 Cost-Utility of Amisulpride Compared with First Generation Antipsychotics in Treatment of Schizophrenia in Poland

PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)

PDB2 Epidemiology, Patient Burden and Related Costs of Obesity in India

PDB8 Bariatric and Metabolic Surgery in India – Efficacy and Safety of Minimally Invasive Procedures

PCV4 Comparative Efficacy of Maintenance of Sinus Rhythm Versus Rate Control Strategies in the Treatment of Atrial Fibrillation – Systematic Review and Meta-Analyses

PIN79 Cost-Utility Analysis of Tenofovir in Comparison with Other Nucleoside Analogues (AN) in Chronic Hepatitis B (CHB) Treatment

PIN2 Safety and Efficacy of Tenofovir as Compared to Other Nucleot(s)ide Analogues in the Treatment of Chronic Hepatitis B – A Systematic review with Mixed Treatment Comparison

Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

Budget Impact Analysis (BIA) Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

PMD95 - Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

PMD32 - Budget Impact Analysis (BIA) Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

PRS40 Cost-Utility of Fluticasone Compared with Beclomethasone and Budesonid in Chronic Obstructive Pulmonary Disease (COPD) in Poland

Suchergebnisse filtern